banner image

Quince Therapeutics Trial Update

We know many families were hoping for encouraging news from the recent Phase 3 trial of eDSP. Sadly, Quince Therapeutics has announced that the treatment did not show the improvement researchers were looking for, and as a result, they will be stopping further development of this therapy.

Please click below to read Quince’s full statement.

https://atsociety.org.uk/wp-content/uploads/2026/01/Negative-P3-NEAT-Topline-Results-Release-FINAL-1.29.26.pdf